2Briggs WA, Choi MJ, Scheel PJ. Follow-up on mycophenolate treatment of glomerular disease[J].Am J Kidney Dis, 1998,32:898-899.
3Adams PL, Iskander SS, Rohr MS. Biopsy-proven resolution of immune complex-mediated crescentic glomerulonephritis with mycophenolate mofetil therapy in an allograft[J].Am J Kidney Dis, 1999,33:552-554.
4Gellermann J, Querfeld U. Frequently relapsing nephrotic syndrome: treatment with mycophenolate mofetil[J].Pediatr Nephrol, 2004,19(1):101-104.
5Weber LT,Shipkova M,Lamersdorf T,et al.Pharmacokinetics of mycophenolic acid (MPA) and determinants of MPA free fraction in pediatric and adult renal transplantate recipients[J].J Am Soc Nephrol,1998,9(8):1511-1520.
6Ronkainen J,Nuutinen M,Koskimies O.The adult kidney 24 years after childhood Henoch-Schonlein purpura:a retrospective cohort study[J].Lancet,2002,360(9334):666-670.
7Huang Y,Liu Z,Huang H,et al.Effects of mycophenolic acid on endothelial cells[J].Int Immunopharmacol,2005,5(6):1029-1039.
8Smyth A, Oliveira GH, Lahr BD, et al. A systematic review and meta - analysis of pregnancy outcomes in patients with systemic lupus erythe- matosus and lupus nephritis [J]. Clin J Am Soc Nephrol, 2010, 5 ( 11 ) : 2060 - 2068.
9Bhowmik D, Sinha S, Gupt A, et al. Clinical approach to rapidly pro- gressive renal failure [ J]. J Assoc Physicians India, 2011, 59:38 -41.
10~vihingsanon Y, Hirankarn N. Major lupus organ involvement: severe upus nephritis [J]. Lupus, 2010, 19 (12) : 1391 -1398.
